Patient Touch ™ Blood Product Administration System v3.2.1
Stand Alone, Blood Bank Software (Source: What's New at CBER)
Source: What's New at CBER - February 24, 2017 Category: Biomedical Science Source Type: news
Gammaplex 5% & 10%
October 7, 2009 letter corrects the storage temperature stated on page 1, paragraph 5. Posted: 12/11/2009 (Source: What's New at CBER)
Source: What's New at CBER - February 7, 2017 Category: Biomedical Science Source Type: news
Guidance Agenda: Guidance Documents CBER is Planning to Publish During Calendar Year 2017
Guidance agenda outling guidance documents CBER is planning to publish during calendar year 2017. (Source: What's New at CBER)
Source: What's New at CBER - January 18, 2017 Category: Biomedical Science Source Type: news
December 5, 2012: Blood Products Advisory Committee: Errata – FDA Briefing Document
(Source: What's New at CBER)
Source: What's New at CBER - October 13, 2016 Category: Biomedical Science Source Type: news
Diphtheria and Tetanus Toxoids Adsorbed
(Source: What's New at CBER)
Source: What's New at CBER - August 5, 2016 Category: Biomedical Science Source Type: news
Patient Touch™ Blood Product Administration System v3.2.1
Stand Alone, Blood Bank Software (Source: What's New at CBER)
Source: What's New at CBER - April 22, 2016 Category: Biomedical Science Source Type: news
Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion; Draft Guidance for Industry
. (Source: What's New at CBER)
Source: What's New at CBER - March 14, 2016 Category: Biomedical Science Source Type: news
Flebogamma DIF 5% & 10%
Updated Package Insert, December 2009. (Source: What's New at CBER)
Source: What's New at CBER - January 22, 2016 Category: Biomedical Science Source Type: news
Guidance Agenda: Guidance Documents CBER is Planning to Publish During Calendar Year 2016
Guidance agenda outling guidance documents CBER is planning to publish during calendar year 2016. (Source: What's New at CBER)
Source: What's New at CBER - January 14, 2016 Category: Biomedical Science Source Type: news
October 27, 2015 Approval Letter - IMLYGIC
IMLYGIC is a genetically modified oncolytic viral therapy indicated for the local treatment of unresectable cutaneous, subcutaneous, and nodal lesions in patients with melanoma recurrent after initial surgery. (Source: What's New at CBER)
Source: What's New at CBER - November 4, 2015 Category: Biomedical Science Source Type: news
Vaccines Licensed for Immunization and Distribution in the US with Supporting Documents
This list includes only vaccines for which supporting documents were provided and is arranged alphabetically by the proper name of the product. Information is provided for original product approvals, new indications, and the current package insert. For a complete list of approved vaccines, click the link under "Related Information" at the bottom of this page. (Source: What's New at CBER)
Source: What's New at CBER - August 19, 2015 Category: Biomedical Science Source Type: news
Order to Cease Manufacturing and to Retain HCT/Ps - Donor Referral Services
(Source: What's New at CBER)
Source: What's New at CBER - August 17, 2015 Category: Biomedical Science Source Type: news
Approval History, Letters, Reviews, and Related Documents - TRETTEN
(Source: What's New at CBER)
Source: What's New at CBER - July 22, 2015 Category: Biomedical Science Source Type: news
Keeping Blood Transfusions Safe: FDA's Multi-layered Protections for Donated Blood
(Source: What's New at CBER)
Source: What's New at CBER - June 11, 2015 Category: Biomedical Science Source Type: news
Bar Code Requirements for Blood Banks
(Source: What's New at CBER)
Source: What's New at CBER - June 10, 2015 Category: Biomedical Science Source Type: news
